4

For a seminar, I am preparing an overview of advantages and shortcomings of randomized control trials (RCT; one shortcoming is, for example, often a limited external validity).

To illustrate potential problems with RCTs, I would like to give some examples of what can go wrong during the implementation of a randomized control design. I remember once being told about the following story of a flawed randomized controlled trial. It goes roughly as follows (I do not remember it exactly):

In the early days of the development of HIV drugs, an AIDS diagnosis often meant an agonizing death. Patients were accordingly in despair. At one point there was a promising drug (which later was shown to have indeed some beneficial effects). This drug was tested for efficacy against a placebo in a double blinded randomized trial. There were no obvious flaws in the randomization protocol or how it was implemented. The results of the initial trials were however a rather precise zero effect. How this could be the case?

The answer is the following (or similar to that):

Patients had to show up repeatedly to receive the treatment or placebo. Patients obviously did not know whether they are in the treatment or the control group. They just knew what the treatment pill could perhaps save or prolong their life. So they took their chance: After receiving the pills, all participants met. In order to ensure that they receive the treatment pill (on average) at least half of the time, they throw all pills into a basket and mixed them again.

I hope I remember this example correctly. I think this is an interesting story about what can go wrong with randomization protocols. However, I cannot find any reference confirming this story!

Could anyone provide me with a source (ideally including further information)?

Are there other similar examples?

Arne Jonas Warnke
  • 3,085
  • 1
  • 22
  • 40
  • 1
    The example you give is a very interesting story! However, I'm not sure it's an issue with RCT's, but rather an issue with patients **breaking** the randomized part of the RCT. – Cliff AB Feb 18 '20 at 19:37
  • 1
    In theory, the major issue with RCT's is that they are a very slow and expensive way to collect information. This can be a barrier to getting effective treatments to the market. Unfortunately, it's really hard to find a story "Treatment X *should* have saved one million lives, but the company couldn't afford to test it". – Cliff AB Feb 18 '20 at 19:39
  • You are right with the fact that undermine the randomization in this example but this is in my view a potential shortcoming with RCTs: you have only on paper full control about what is going on and how humans behave in or outside the lab. – Arne Jonas Warnke Feb 18 '20 at 19:52
  • "Limited external validity" is often misunderstood. See https://fharrell.com/rct-mimic which discusses why this is less of a problem than it appears. – Frank Harrell Dec 09 '21 at 11:49
  • @FrankHarrell the link unfortunately does not work on my computer (404 Page not found) – Arne Jonas Warnke Dec 09 '21 at 11:56
  • Very sorry - should be https://fharrell.com/post/rct-mimic – Frank Harrell Dec 09 '21 at 12:09

0 Answers0